Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carroll

Showing results (631-640 of 26,015) with videos related to

Pageof 2,602
Sort By:
Biotechnology Healthcare|December 26, 2012
As REMS Requirements Simplify, Participants Need To Catch UpJohn Carroll
Biotechnology Healthcare|April 6, 2012
Money-Back Guarantees: Where Private Payers Might Not Wait for CMS To LeadJohn Carroll
Biotechnology Healthcare|April 6, 2012
The next generation: strong, specializedJohn Carroll
Biotechnology Healthcare|April 6, 2012
Peeling back the onionJohn Carroll
Biotechnology Healthcare|April 6, 2012
When a negative becomes a positive: GIC bucks the high-cost trendJohn Carroll
Biotechnology Healthcare|April 6, 2012
Industry meeting demands for more effective vaccinesJohn Carroll
Biotechnology Healthcare|April 6, 2012
Weeding out waste in benefit designJohn Carroll
Biotechnology Healthcare|April 6, 2012
Copayment subsidiesJohn Carroll
Biotechnology Healthcare|April 6, 2012
Mixing Personalized Medicine and CER, One Specialty Pharmacy Plows New GroundJohn Carroll
Biotechnology Healthcare|February 2, 2013
The unpredictable path from group to individual policiesJohn Carroll
Pageof 2,602

Showing results (631-640 of 26,015) with videos related to

Sort By:
Pageof 2,602
Biotechnology Healthcare|December 26, 2012
As REMS Requirements Simplify, Participants Need To Catch UpJohn Carroll
Biotechnology Healthcare|April 6, 2012
Money-Back Guarantees: Where Private Payers Might Not Wait for CMS To LeadJohn Carroll
Biotechnology Healthcare|April 6, 2012
The next generation: strong, specializedJohn Carroll
Biotechnology Healthcare|April 6, 2012
Peeling back the onionJohn Carroll
Biotechnology Healthcare|April 6, 2012
When a negative becomes a positive: GIC bucks the high-cost trendJohn Carroll
Biotechnology Healthcare|April 6, 2012
Industry meeting demands for more effective vaccinesJohn Carroll
Biotechnology Healthcare|April 6, 2012
Weeding out waste in benefit designJohn Carroll
Biotechnology Healthcare|April 6, 2012
Copayment subsidiesJohn Carroll
Biotechnology Healthcare|April 6, 2012
Mixing Personalized Medicine and CER, One Specialty Pharmacy Plows New GroundJohn Carroll
Biotechnology Healthcare|February 2, 2013
The unpredictable path from group to individual policiesJohn Carroll
Pageof 2,602